Latest News

Fluorescent compounds allow clinicians to visualize Alzheimer's disease as it progresses

What if doctors could visualize all of the processes that take place in the brain during the development and progression of Alzheimer's disease? Such a window would provide a powerful aid for diagnosing the condition. Now, researchers have developed a new class of imaging agents that enables them to visualize tau protein aggregates, a pathological hallmark of Alzheimer's disease and related neurodegenerative disorders, directly in the brains of living patients.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Scientists seen as competent but not trusted by Americans

  • Job loss fears may boost first-time asthma risk

  • Safe passages into adulthood: Preventing gender-based violence and its consequences

  • Foot drop stimulator found to be beneficial in stroke rehab

  • 'Brain Breaks' increase activity, educational performance in elementary schools

  • Surveys may assess language more than attitudes, says study

  • Dying brain cells cue new brain cells to grow in songbird

  • Firelight talk of the Kalahari Bushmen: Did tales told over fires aid our social and cultural evolution?

  • Statin use during hospitalization for hemorrhagic stroke associated with improved survival

  • Few kids receive psychotherapy along with medication for ADHD, study finds

  •